Kochenderfer, J. N., Dudley, M. E., Carpenter, R. O., Kassim, S. H., Rose, J. J., Telford, W. G., . . . Rosenberg, S. A. (2013). Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. American Society of Hematology.
シカゴスタイル引用形Kochenderfer, James N., et al. Donor-derived CD19-targeted T Cells Cause Regression of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation. American Society of Hematology, 2013.
MLA引用形式Kochenderfer, James N., et al. Donor-derived CD19-targeted T Cells Cause Regression of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation. American Society of Hematology, 2013.
警告: この引用は必ずしも正確ではありません.